Cited by 5,504Antiplatelet Therapy and Cardiovascular DiseasesLipoproteins and Cardiovascular HealthInflammatory Biomarkers in Disease Prognosis

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

Open access

Ridker, Paul M., Cushman, Mary, Stampfer, Meir J., Tracy, Russell P., Hennekens, Charles H.·1997·New England Journal of Medicine

DOI 10.1056/nejm199704033361401

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Inflammation may be important in the pathogenesis of atherothrombosis. We studied whether inflammation increases the risk of a first thrombotic event and whether treatment with aspirin decreases the risk. METHODS: We measured plasma C-reactive protein, a marker for systemic inflammation, in 543 apparently healthy men participating in the Physicians' Health Study in whom myocardial infarction, stroke, or venous thrombosis subsequently developed, and in 543 study participants who did not report vascular disease during a follow-up period exceeding eight years. Subjects were randomly assigned to receive aspirin or placebo at the beginning of the trial. RESULTS: Base-line plasma C-reactive protein concentrations were higher among men who went on to have myocardial infarction (1.51 vs. 1.13 mg per liter, P<0.001) or ischemic stroke (1.38 vs. 1.13 mg per liter, P=0.02), but not venous thrombosis (1.26 vs. 1.13 mg per liter, P=0.34), than among men without vascular events. The men in the quartile with the highest levels of C-reactive protein values had three times the risk of myocardial infarction (relative risk, 2.9; P<0.001) and two times the risk of ischemic stroke (relative risk, 1.9; P=0.02) of the men in the lowest quartile. Risks were stable over long periods, were not modified by smoking, and were independent of other lipid-related and non-lipid-related risk factors. The use of aspirin was associated with significant reductions in the risk of myocardial infarction (55.7 percent reduction, P=0.02) among men in the highest quartile but with only small, nonsignificant reductions among those in the lowest quartile (13.9 percent, P=0.77). CONCLUSIONS: The base-line plasma concentration of C-reactive protein predicts the risk of future myocardial infarction and stroke. Moreover, the reduction associated with the use of aspirin in the risk of a first myocardial infarction appears to be directly related to the level of C-reactive protein, raising the possibility that antiinflammatory agents may have clinical benefits in preventing cardiovascular disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199704033361401

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimón, L., Badimón, L., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,792
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimón, L., Badimón, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260406 · Cited by 2,713
Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease
Hennekens, C. H., Buring, J. E., Manson, J. E., Stampfer, M., Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341801 · Cited by 2,397
Self-citation
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,354
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.
van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,921
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
Thompson, S. G., Kienast, J., Pyke, S., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,819
Coronary Plaque Erosion Without Rupture Into a Lipid Core
Farb, A. A., BURKE, A. P., Tang, A. L., Liang, Y.-H., Mannan, P., Smialek, J. E., & Virmani, R. (1996) · Circulation · doi:10.1161/01.cir.93.7.1354 · Cited by 1,272
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108083250601 · Cited by 1,163
Self-citation

Show all 36 references

Research works printed but not linked: 1

Munro JM, 1988, Lab Invest, 58, 249

Sorted by citations

Items 101–197 of 197

Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects
Meier-Ewert, H. K., Ridker, P. M., Rifai, N., Price, N., Dinges, D. F., & Mullington, J. M. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.426 · Cited by 410
Self-citation
Coming of Age of C-Reactive Protein: Using Inflammation Markers in Cardiology
Yeh, E. T. H., & Willerson, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000053731.05365.5a · Cited by 403
Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease
Sabatine, M. S., Morrow, D. A., Jablonski, K. A., Rice, M. M., Warnica, J. W., Domanski, M. J., Hsia, J., Gersh, B. J., Rifai, N., Ridker, P. M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.649939 · Cited by 385
Self-citation
Relation between markers of systemic vascular inflammation and smoking in women
Bermudez, E. A., Rifai, N., Buring, J. E., Manson, J. E., & Ridker, P. M. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02284-1 · Cited by 385
Self-citation
Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis
PRODANOWICH, S., MA, F., TAYLOR, J., PEZON, C., FASIHI, T., & KIRSNER, R. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.06.017 · Cited by 384
Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis
Everett, B. M., Pradhan, A. D., Solomon, D. H., Paynter, N., MacFadyen, J., Zaharris, E., Gupta, M., Clearfield, M., Libby, P., Hasan, A. A. K., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.03.018 · Cited by 368
Self-citation
The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: A systematic review
Schoenfeld, S. R., Kasturi, S., & Costenbader, K. H. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2012.12.002 · Cited by 370
Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey
de Oliveira, C., Watt, R., & Hamer, M. (2010) · BMJ · doi:10.1136/bmj.c2451 · Cited by 365
Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation
Amar, S., Gokce, N., Morgan, S., Loukideli, M., Van Dyke, T. E., & Vita, J. A. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000078603.90302.4a · Cited by 361
Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity
Donath, M. Y., Dalmas, É., Sauter, N. S., & Böni-Schnetzler, M. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.001 · Cited by 338
Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT
Bohula, E. A., Giugliano, R. P., Cannon, C. P., Zhou, J., Murphy, S. A., White, J. A., Tershakovec, A. M., Blazing, M. A., & Braunwald, E. (2015) · Circulation · doi:10.1161/circulationaha.115.018381 · Cited by 340
Association Between Depression and Elevated C-Reactive Protein
Danner, M., Kasl, S. V., Abramson, J. L., & Vaccarino, V. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000041542.29808.01 · Cited by 341
Energy Restriction and Weight Loss on Very-Low-Fat Diets Reduce C-Reactive Protein Concentrations in Obese, Healthy Women
Heilbronn, L. K., Noakes, M., & Clifton, P. M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.6.968 · Cited by 331
Inflammatory Markers and Incident Mobility Limitation in the Elderly
Penninx, B. W. J. H., Kritchevsky, S. B., Newman, A. B., Nicklas, B. J., Simonsick, E. M., Rubin, S., Nevitt, M., Visser, M., Harris, T., & Pahor, M. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52308.x · Cited by 326
The effects of 40 hours of total sleep deprivation on inflammatory markers in healthy young adults
Frey, D. J., Fleshner, M., & Wright, K. P. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.04.003 · Cited by 330
Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions
Savoia, C., & Schiffrin, E. L. (2007) · Clinical Science · doi:10.1042/cs20060247 · Cited by 326
High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy
Koenig, W. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.113 · Cited by 315
Effect of exercise training on C reactive protein: a systematic review and meta-analysis of randomised and non-randomised controlled trials
Fedewa, M. V., Hathaway, E. D., & Ward-Ritacco, C. L. (2017) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-095999 · Cited by 309
Sarcopenic-obesity and cardiovascular disease risk in the elderly
Stephen, W. C., & Janssen, I. (2009) · The Journal of nutrition, health and aging · doi:10.1007/s12603-009-0084-z · Cited by 301
Reduction in C-reactive protein through cardiac rehabilitation and exercise training
Milani, R. V., Lavie, C. J., & Mehra, M. R. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.041 · Cited by 302
Cyclooxygenase-2 Is Widely Expressed in Atherosclerotic Lesions Affecting Native and Transplanted Human Coronary Arteries and Colocalizes With Inducible Nitric Oxide Synthase and Nitrotyrosine Particularly in Macrophages
Baker, C. S. R., Hall, R. J. C., Evans, T. J., Pomerance, A., Maclouf, J., Creminon, C., Yacoub, M. H., & Polak, J. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.646 · Cited by 296
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH
Yoneda, M., Mawatari, H., Fujita, K., Iida, H., Yonemitsu, K., Kato, S., Takahashi, H., Kirikoshi, H., Inamori, M., Nozaki, Y., et al. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2060-x · Cited by 294
Supplementation With Conjugated Linoleic Acid Causes Isomer-Dependent Oxidative Stress and Elevated C-Reactive Protein: A Potential Link to Fatty Acid-Induced Insulin Resistance
Risérus, U., Basu, S., Jovinge, S., Fredrikson, G. N., Ärnlöv, J., & Vessby, B. (2002) · Circulation · doi:10.1161/01.cir.0000033589.15413.48 · Cited by 292
High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: From concept to clinical practice to clinical benefit
Ridker, P. M. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.04.028 · Cited by 290
Self-citation
Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies
Nazmi, A., & Victora, C. G. (2007) · BMC Public Health · doi:10.1186/1471-2458-7-212 · Cited by 291
Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial
Jones, M. L., Martoni, C. J., & Prakash, S. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.126 · Cited by 277
Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
Ridker, P. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313129 · Cited by 260
Self-citation
Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
Davidson, M. H., Ballantyne, C. M., Jacobson, T. A., Bittner, V. A., Braun, L. T., Brown, A. S., Brown, W. V., Cromwell, W. C., Goldberg, R. B., McKenney, J. M., et al. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.07.005 · Cited by 262
Association of Polymorphisms in the CRP Gene With Circulating C-Reactive Protein Levels and Cardiovascular Events
Lange, L. A., Carlson, C. S., Hindorff, L. A., Lange, E. M., Walston, J., Durda, J. P., Cushman, M., Bis, J. C., Zeng, D., Lin, D., et al. (2006) · JAMA · doi:10.1001/jama.296.22.2703 · Cited by 266
Self-citation
Early Inflammation and Risk of Long-Term Development of Heart Failure and Mortality in Survivors of Acute Myocardial Infarction
Suleiman, M., Khatib, R., Agmon, Y., Mahamid, R., Boulos, M., Kapeliovich, M., Levy, Y., Beyar, R., Markiewicz, W., Hammerman, H., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.055 · Cited by 264
Effects of Growth Hormone Administration on Inflammatory and Other Cardiovascular Risk Markers in Men with Growth Hormone Deficiency: A Randomized, Controlled Clinical Trial
Sesmilo, G., Biller, B. M. K., Llevadot, J., Hayden, D., Hanson, G., Rifai, N., & Klibanski, A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-2-200007180-00010 · Cited by 257
Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training
Nicklas, B. J. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040769 · Cited by 259
Biologic cost of caring for a cancer patient: dysregulation of pro- and anti-inflammatory signaling pathways
Rohleder, N., Marin, T. J., Ma, R., & Miller, G. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7435 · Cited by 252
Periodontal infection is associated with endothelial dysfunction in healthy subjects and hypertensive patients
Higashi, Y., Goto, C., Jitsuiki, D., Umemura, T., Nishioka, K., Hidaka, T., Takemoto, H., Nakamura, S., Soga, J., Chayama, K., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.101535 · Cited by 250
Sleep duration, cardiovascular disease, and proinflammatory biomarkers
Grandner, M., Sands-Lincoln, Pak, & Garland (2013) · Nature and Science of Sleep · doi:10.2147/nss.s31063 · Cited by 246
Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men
Lampert, R., Bremner, J. D., Su, S., Miller, A., Lee, F., Cheema, F., Goldberg, J., & Vaccarino, V. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.07.009 · Cited by 240
Tetrahydrobiopterin in Cardiovascular Health and Disease
Bendall, J. K., Douglas, G., McNeill, E., Channon, K. M., & Crabtree, M. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5566 · Cited by 231
Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study
Sierksma, A., van der Gaag, M., Kluft, C., & Hendriks, H. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601459 · Cited by 231
The Metabolic Syndrome and Inflammation
Sutherland, J. P., McKinley, B., & Eckel, R. H. (2004) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2004.2.82 · Cited by 243
Impact of obesity on cardiovascular disease
Zalesin, K. C., Franklin, B. A., Miller, W. M., Peterson, E. D., & McCullough, P. A. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.06.005 · Cited by 231
Association of Common CRP Gene Variants with CRP Levels and Cardiovascular Events
Miller, D. T., Zee, R. Y. L., Suk Danik, J., Kozlowski, P., Chasman, D. I., Lazarus, R., Cook, N. R., Ridker, P. M., & Kwiatkowski, D. J. (2005) · Annals of Human Genetics · doi:10.1111/j.1529-8817.2005.00210.x · Cited by 220
Self-citation
Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
Sharif, S., Van der Graaf, Y., Cramer, M. J., Kapelle, L. J., de Borst, G. J., Visseren, F. L. J., Westerink, J., the SMART study group, van Petersen, R., Dinther, B. G. F., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01409-0 · Cited by 198
C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease
Ridker, P. M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.119214 · Cited by 206
Self-citation
Advanced glycation end products and mortality in hemodialysis patients
Schwedler, S. B., Metzger, T., Schinzel, R., & Wanner, C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00423.x · Cited by 195
High-Sensitivity C-Reactive Protein and Coronary Heart Disease Mortality in Patients With Type 2 Diabetes
Soinio, M., Marniemi, J., Laakso, M., Lehto, S., & Rönnemaa, T. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1700 · Cited by 186
Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women
Suarez, E. C., Lewis, J. G., Krishnan, R. R., & Young, K. H. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.01.002 · Cited by 185
Effect of physical activity on serum C-reactive protein
Albert, M. A., Glynn, R. J., & Ridker, P. M. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.046 · Cited by 178
Self-citation
C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians
Windgassen, E. B., Funtowicz, L., Lunsford, T. N., Harris, L. A., & Mulvagh, S. L. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.01.2252 · Cited by 170
Radiation dose-dependent increases in inflammatory response markers in a-bomb survivors
Hayashi, T., Kusunoki, Y., Hakoda, M., Morishita, Y., Kubo, Y., Maki, M., Kasagi, F., Kodama, K., Macphee, D. G., & Kyoizumi, S. (2003) · International Journal of Radiation Biology · doi:10.1080/0955300021000038662 · Cited by 172
Effects of black tea consumption on plasma catechins and markers of oxidative stress and inflammation in patients with coronary artery disease
Widlansky, M. E., Duffy, S. J., Hamburg, N. M., Gokce, N., Warden, B. A., Wiseman, S., Keaney, J. F., Frei, B., & Vita, J. A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.11.013 · Cited by 162
Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review
Garza, C. A., Montori, V. M., McConnell, J. P., Somers, V. K., Kullo, I. J., & Lopez-Jimenez, F. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60992-0 · Cited by 159
Early life adversity exposure and circulating markers of inflammation in children and adolescents: A systematic review and meta-analysis
Kuhlman, K. R., Horn, S. R., Chiang, J. J., & Bower, J. E. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.04.028 · Cited by 163
Physiological correlates of bereavement and the impact of bereavement interventions
Buckley, T., Sunari, D., Marshall, A., Bartrop, R., McKinley, S., & Tofler, G. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.2/tbuckley · Cited by 160
Plasma C-reactive protein and homocysteine concentrations are related to frequent fruit and vegetable intake in Hispanic and non-Hispanic white elders
Gao, X., Bermudez, O. I., & Tucker, K. L. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.4.913 · Cited by 158
Periodontal therapy and cardiovascular risk
Orlandi, M., Graziani, F., & D'Aiuto, F. (2020) · Periodontology 2000 · doi:10.1111/prd.12299 · Cited by 155
Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH Study
Yudkin, J. S., Juhan-Vague, I., Hawe, E., Humphries, S. E., di Minno, G., Margaglione, M., Tremoli, E., Kooistra, T., Morange, P. E., Lundman, P., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2004.02.004 · Cited by 153
Body Mass Index, but Not Physical Activity, Is Associated with C-Reactive Protein
RAWSON, E. S., FREEDSON, P. S., OSGANIAN, S. K., MATTHEWS, C. E., REED, G., & OCKENE, I. S. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000074565.79230.ab · Cited by 144
C‐reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin‐sensitizing treatment with thiazolidinediones
Nesto, R. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01296.x · Cited by 140
Clinical implications for statin pleiotropy
Liao, J. K. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000191913.16321.60 · Cited by 139
Is periodontal inflammation associated with raised blood pressure? Evidence from a National US survey
Tsakos, G., Sabbah, W., Hingorani, A. D., Netuveli, G., Donos, N., Watt, R. G., & D'Aiuto, F. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833e0fe1 · Cited by 134
Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes
Tremblay, A. J., Lamarche, B., Deacon, C. F., Weisnagel, S. J., & Couture, P. (2014) · Metabolism · doi:10.1016/j.metabol.2014.06.004 · Cited by 132
Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study
Liao, D., Heiss, G., Chinchilli, V. M., Duan, Y., Folsom, A. R., Lin, H.-M., & Salomaa, V. (2005) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/sj.jea.7500408 · Cited by 129
Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT
Ciubotaru, I., Lee, Y.-S., & Wander, R. C. (2003) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(03)00101-3 · Cited by 127
Inflammation and cortisol response in coronary artery disease
Nijm, J., & Jonasson, L. (2009) · Annals of Medicine · doi:10.1080/07853890802508934 · Cited by 128
Release of sphingosine‐1‐phosphate from human platelets is dependent on thromboxane formation
ULRYCH, T., BÖHM, A., POLZIN, A., DAUM, G., NÜSING, R. M., GEISSLINGER, G., HOHLFELD, T., SCHRÖR, K., & RAUCH, B. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04194.x · Cited by 124
Effects of Initiating Insulin and Metformin on Glycemic Control and Inflammatory Biomarkers Among Patients With Type 2 Diabetes: The LANCET Randomized Trial
Pradhan, A. D., Everett, B. M., Cook, N. R., Rifai, N., & Ridker, P. M. (2009) · JAMA · doi:10.1001/jama.2009.1347 · Cited by 117
Self-citation
C-Reactive Protein: Clinical and Epidemiological Perspectives
Salazar, J., Martínez, M. S., Chávez, M., Toledo, A., Añez, R., Torres, Y., Apruzzese, V., Silva, C., Rojas, J., & Bermúdez, V. (2014) · Cardiology Research and Practice · doi:10.1155/2014/605810 · Cited by 117
Co-morbidity in rheumatoid arthritis
Mikuls, T. R. (2003) · Best Practice & Research Clinical Rheumatology · doi:10.1016/s1521-6942(03)00041-x · Cited by 122
Cardiovascular Risk in Rheumatoid Arthritis: Comparing TNF-α Blockade with Nonbiologic DMARDs
Solomon, D. H., Curtis, J. R., Saag, K. G., Lii, J., Chen, L., Harrold, L. R., Herrinton, L. J., Graham, D. J., Kowal, M. K., Kuriya, B., et al. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.02.016 · Cited by 111
High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes
McDonald, T. J., Shields, B. M., Lawry, J., Owen, K. R., Gloyn, A. L., Ellard, S., & Hattersley, A. T. (2011) · Diabetes Care · doi:10.2337/dc11-0323 · Cited by 105
Increased CRP levels may be a trait marker of suicidal attempt
Courtet, P., Jaussent, I., Genty, C., Dupuy, A. M., Guillaume, S., Ducasse, D., & Olié, E. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.05.003 · Cited by 96
Inflammatory cardiovascular risk markers in women with hypopituitarism
Sesmilo, G., Miller, K. K., Hayden, D., & Klibanski, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8087 · Cited by 97
Moderate alcohol intake and markers of inflammation and endothelial dysfunction among diabetic men
Shai, I., Rimm, E. B., Schulze, M. B., Rifai, N., Stampfer, M. J., & Hu, F. B. (2004) · Diabetologia · doi:10.1007/s00125-004-1526-0 · Cited by 83
C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss
Heilbronn, L. K., & Clifton, P. M. (2002) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(02)00187-0 · Cited by 80
Cigarette smoking and risk of coronary heart disease incidence among middle-aged Japanese men and women: the JPHC Study Cohort I
Baba, S., Iso, H., Mannami, T., Sasaki, S., Okada, K., Konishi, M., & Tsugane, S. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000194417.16638.3d · Cited by 79
Central autonomic network mediates cardiovascular responses to acute inflammation: relevance to increased cardiovascular risk in depression?
Harrison, N. A., Cooper, E., Voon, V., Miles, K., & Critchley, H. D. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.02.001 · Cited by 76
Plasma Fibrinogen as a Predictor of Total and Cause-Specific Mortality in Elderly Japanese-American Men
Yano, K., Grove, J. S., Chen, R., Rodriguez, B. L., Curb, J. D., & Tracy, R. P. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.6.1065 · Cited by 76
Self-citation
Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice
Yamamoto, S., Zuo, Y., Ma, J., Yancey, P. G., Hunley, T. E., Motojima, M., Fogo, A. B., Linton, M. F., Fazio, S., Ichikawa, I., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq759 · Cited by 74
Alcohol consumption and inflammatory markers in older adults: the Cardiovascular Health Study
Mukamal, K. J., Cushman, M., Mittleman, M. A., Tracy, R. P., & Siscovick, D. S. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.10.011 · Cited by 65
Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A
Visseren, F. L. J., Verkerk, M. S. A., Van Der Bruggen, T., Marx, J. J. M., Van Asbeck, B. S., & Diepersloot, R. J. A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1084.x · Cited by 64
High Sensitivity Immunoassays for C-Reactive Protein: Promises and Pitfalls
Ledue, T. B., & Rifai, N. (2001) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2001.185 · Cited by 60
Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers
Tousoulis, D. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00250-8 · Cited by 60
Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM
Coppola, G., Corrado, E., Muratori, I., Tantillo, R., Vitale, G., Lo Coco, L., & Novo, S. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.12.051 · Cited by 55
Inflammation and thrombosis – testing the hypothesis with anti- inflammatory drug trials
D’Ugo, E., Libby, P., & De Caterina, R. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-03-0246 · Cited by 54
The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure
Madsen, T., Schmidt, E. B., & Christensen, J. H. (2007) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2007.03.003 · Cited by 52
Transforming growth factor-β and inflammation in vascular (type IV) Ehlers-Danlos syndrome
Morissette, R., Schoenhoff, F., Xu, Z., Shilane, D. A., Griswold, B. F., Chen, W., Yang, J., Zhu, J., Fert-Bober, J., Sloper, L., et al. (2014) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.113.000280 · Cited by 51
Association of fear of terror with low-grade inflammation among apparently healthy employed adults
Melamed, S., Shirom, A., Toker, S., Berliner, S., & Shapira, I. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000130963.52755.b9 · Cited by 51
Reference distributions for serum iron and transferrin saturation: a practical, simple, and clinically relevant approach in a large cohort
Ritchie, R. F., Palomaki, G. E., Neveux, L. M., Navolotskaia, O., Ledue, T. B., & Craig, W. Y. (2002) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.10048 · Cited by 48
The Impact of C-Reactive Protein on Risk of Stroke, Stroke Subtypes, and Ischemic Heart Disease in Middle-Aged Japanese: the Japan Public Health Center-Based Study
Iso, H., Noda, H., Ikeda, A., Yamagishi, K., Inoue, M., Iwasaki, M., & Tsugane, S. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11999 · Cited by 48
C-reactive protein: a surrogate risk marker or mediator of atherothrombosis?
Blake, G. J., & Ridker, P. M. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00227.2003 · Cited by 47
Self-citation
Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia
Blake, G. J., Ridker, P. M., & Kuntz, K. M. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00074-3 · Cited by 44
Self-citation
Examination of the efficacy of acute L-alanyl-L-glutamine ingestion during hydration stress in endurance exercise
Hoffman, J. R., Ratamess, N. A., Kang, J., Rashti, S. L., Kelly, N., Gonzalez, A. M., Stec, M., Anderson, S., Bailey, B. L., Yamamoto, L. M., et al. (2010) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-7-8 · Cited by 41
C-reactive protein levels and risk of stroke and its subtype in Japanese: The Circulatory Risk in Communities Study (CIRCS)
Chei, C.-L., Yamagishi, K., Kitamura, A., Kiyama, M., Imano, H., Ohira, T., Cui, R., Tanigawa, T., Sankai, T., Ishikawa, Y., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.001 · Cited by 38
The effects of eicosapentaenoic acid-fortified food on inflammatory markers in healthy subjects – a randomized, placebo-controlled, double-blind study
FUJIOKA, S., HAMAZAKI, K., ITOMURA, M., HUAN, M., NISHIZAWA, H., SAWAZAKI, S., KITAJIMA, I., & HAMAZAKI, T. (2006) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.52.261 · Cited by 36
Cardiovascular morbidity and mortality in Finnish men and women separated temporarily from their parents in childhood–a life course study
Alastalo, H., Räikkönen, K., Pesonen, A.-K., Osmond, C., Barker, D. J. P., Heinonen, K., Kajantie, E., & Eriksson, J. G. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31825b3d76 · Cited by 32
Gender and asthma
Fuhlbrigge, A. L., Jackson, B., & Wright, R. J. (2002) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(02)00022-x · Cited by 32
Dispositional depression and hostility are associated with inflammatory markers of cardiovascular disease in African Americans
Mwendwa, D. T., Ali, M. K., Sims, R. C., Cole, A. P., Lipscomb, M. W., Levy, S.-A., Callender, C. O., & Campbell, A. L. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.019 · Cited by 27

Authors: Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H.
Affiliations: Brigham and Women's Hospital (US)
University of Vermont (US)
ORCID: Ridker, Paul M.
Cushman, Mary
Stampfer, Meir J.
Tracy, Russell P.
Hennekens, Charles H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1997-04-03
Volume: 336
Issue: 14
Pages: 973-979
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199704033361401
OpenAlex: W2316376271
Cited by: 5,504
References: 36
Citations by year: 2026: 67 · 2025: 81 · 2024: 77 · 2023: 92 · 2022: 95 · 2021: 103 · 2020: 100 · 2019: 115 · 2018: 107 · 2017: 98 · 2016: 114 · 2015: 135 · 2014: 141 · 2013: 171 · 2012: 164
FWCI: 148.83
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: American Heart Association
National Institutes of Health (CA 34944, CA 40360, HL-26490)
National Heart, Lung, and Blood Institute (HL-34595, R01HL046690, HL 26490, HL-46690, R01HL034595)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Keywords: C-reactive protein, inflammation, aspirin, cardiovascular disease, myocardial infarction, ischemic stroke, venous thrombosis, atherothrombosis, anti-inflammatory therapy, cardiovascular risk prediction, Physicians' Health Study
MeSH terms: Adult, Aged, Aged, 80 and over, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, C-Reactive Protein, Brain Ischemia, Humans, Inflammation, Male, Middle Aged, Myocardial Infarction, Risk, Thrombophlebitis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks